Log In
BCIQ
Print this Print this
 

CRC-02

  Manage Alerts
Collapse Summary General Information
Company Igenica Inc.
DescriptionAntibody-drug conjugate
Molecular Target
Mechanism of ActionAntibody-drug conjugate
Therapeutic ModalityBiologic: Antibody-drug conjugate
Latest Stage of DevelopmentPreclinical
Standard IndicationColorectal cancer
Indication DetailsTreat colorectal cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today